Efficacy and safety of buprenorphine TDS in conjunction with oral tramadol or morphine as rescue medication in the treatment of 390 patients with chronic pain: A summary of Two retrospective spanish multicenter studies

Journal of Applied Therapeutic Research

Volumn 6, Issue 2, 2007, Pages 14-24

  De Barutell, Carlos ^a   González Escalada, José Ramón ^b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Buprenorphine; Cancer pain; Chronic pain; Morphine; Opioids; Tramadol; Transdermal therapeutic systems

Indexed keywords

EID: 59249108388     PISSN: 10292659     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Anon (2003). Transtec Summary of Product Characteristics. Spain, Grünenthal.
2. Armitage, P. & Berry, G. (1994). Statistical Methods in Medical Research. Oxford, UK, Blackwell.
3. Atkinson, R., Schofield, P. & Mellor, P. (1990). The efficacy in sequential use of buprenorphine and morphine in advanced cancer pain. In Doyle, D. (Ed.) Opioids in the Treatment of Cancer Pain. London, Royal Society Of Medicine.
4. Böhme, K. & Likar, R. (2003). Efficacy and tolerability of a new opioid analgesic formulation, buprenorphine transdermal therapeutic system (TDS), in the treatment of patients with chronic pain. A randomised, double-blind, placebo-controlled study. The Pain Clinic, 15, 193-202.
5. Budd, K. (1983). Buprenorphine. Clin Anaesthesiol, 1, 147-79.
6. Budd, K. (2002). Buprenorphine: A review. Evidence Based Medicine in Practice.
7. Dahan, A., Cowan, A., Foley, KM., Friderichs, E., Glynn, CJ., Hans, G., Kress, HG., Mercadante, S., Tornero Molina, J., Preston, KL., Sacerdote, P., Shipton, EA., Sittl, R. & Strassburger, W. (2005). Buprenorphine - The Unique Opioid Analgesic. Stuttgart, Georg Thieme Verlag.
8. de Barutell, C. (2004). Y Grupo de Estudio de Opiodes de Sociedad Española del Dolor. Buprenorfina y tramadol. Rev Soc Esp Dolor, 11, 31-40.
9. Evans, HC. & Easthope, SE. (2003). Transdermal buprenorphine. Drugs, 63, 1999-2010; Discussion 2011-2.
10. González-Escalada, JR. (2004) Y Grupo de Estudio de Opiodes de La Sociedad Española del Dolor. Utilizacíon conjunta de buprenorfina transdérmica y morfina oral en pacientes con dolor crónico. Rev Soc Esp Dolor, 11, 3-10.
11. Griessinger, N., Sittl, R. & Likar, R. (2005). Transdermal buprenorphine in clinical practice - A post-marketing surveillance study in 13, 179 patients. Curr Med Res Opin, 21, 1147-56.
12. Johnson, RE., Fudala, PJ. & Payne, R. (2005). Buprenorphine: Considerations for pain management. J Pain Symptom Manage, 29, 297-326.
13. Kögel, B., Christoph, T., Strassburger, W. & Friderichs, E. (2005). Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice. Eur J Pain, 9, 599-611.
14. Lewis, JW. (1985). Buprenorphine. Drug Alcohol Depend, 14, 363-72.
15. Likar, R. (2006). Transdermal buprenorphine in the management of persistent pain - safety aspects. Therapeutics And Clinical Risk Management 2 115-125.
16. Likar, R., Kayser, H. & Sittl, R. (2006). Long-term management of chronic pain with transdermal buprenorphine: A multicenter, open-label, follow-up study in patients from three short-term clinical trials. Clin Ther, 28, 943-52.
17. Muriel, C, Failde, I., Mico, JA., Neira, M. & Sanchez-Magro, I. (2005). Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain: A multicenter, open-label, uncontrolled, prospective, observational clinical study. Clin Ther, 27, 451-62.
18. Rodriguez-Lopez, MJ. (2004). The opioid study group of the Spanish Pain Society. Transdermal buprenorphine in the management of neuropathic pain. Rev Soc Esp Dolor, (Suppl V), 11-21.
19. Sittl, R., Griessinger, N. & Likar, R. (2003). Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: A multicenter, randomized, double-blind, placebo-controlled trial. Clin Ther, 25, 150-68.
20. Sorge, J. & Sittl, R. (2004). Transdermal buprenorphine in the treatment of chronic pain: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled study. Clin Ther, 26, 1808-20.